4.5 Editorial Material

Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis

Journal

JOURNAL OF TRAVEL MEDICINE
Volume 28, Issue 2, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jtm/taab011

Keywords

COVID-19; mutation; transmission advantage; reproduction number; statistical modelling; B.1.1.7 lineage

Funding

  1. CUHK [PIEF/Ph2/COVID/06, 4054456]
  2. Health and Medical Research Fund (HMRF) Commissioned Research of Hong Kong, China [COVID190103, INF-CUHK-1]
  3. National Natural Science Foundation of China (NSFC) [31871340, 71974165]

Ask authors/readers for more resources

The N501Y mutation in the UK is rapidly becoming prevalent and poses a major challenge for COVID-19 control. Studies show that this mutation increases the infectivity of the virus by 52%, highlighting the need for increased vigilance and control measures.
The emerging N501Y mutation in severe acute respiratory syndrome coronavirus 2, which becomes prevalent in the UK rapidly, is one of the major challenges of COVID-19 control. To explore the transmission advantage, we estimate that the N501Y substitution increases the infectivity by 52% (95% confidence interval: 46, 58) in terms of the reproduction number.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available